Seikagaku
Manufacturing · Japan · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Marunouchi Center Building 6-1 10fl, Chi...Phone Number
+81 352208950Website
www.seikagaku.co.jpRevenue
$45 MillionStock Symbol
4548Industry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Seikagaku
Founded in 1947, Seikagaku Corporation creates a range of medical devices and pharmaceuticals specifically related to glycoconjugates.Explore more
Seikagaku Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Seikagaku your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Seikagaku, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Seikagaku has new funding data
Earning: See what the market has to say on Seikagaku recently announced quarterly report
Check out if Seikagaku is spiking on competitors!
Check if Seikagaku has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Seikagaku
Click to see if Seikagaku had a recent Job posting/layoffs
Product Launch: Get notified when Seikagaku launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Seikagaku is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Seikagaku is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Seikagaku.
Seikagaku Tech Stack
A closer look at the technologies used by Seikagaku
Seikagaku News & Media
Ferring Presents Efficacy and Safety Data From Two Phase 3 Studies for Investigational Treatment, SI-6603 (condoliase), in Lumbar Disc Herniation at NASS 2024
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring presents efficacy and safety data for SI-6603 (condoliase) in lumbar disc herniation at NASS 2024Ferring to Present New Data Analysis at NASS 2024 for SI-6603, an Investigational Treatment for Lumbar Disc Herniation
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring to present new data analysis at NASS 2024 for SI-6603, an investigational treatment for Lumbar Disc HerniationFerring Presents Early Response Data From Pivotal Phase 3 Trial for Investigational Treatment, SI-6603 (condoliase), in Lumbar Disc Herniation at ASPN 2024
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring presents early response data from pivotal Phase 3 trial for SI-6603 (condoliase) at ASPN 2024Ferring to Present New Data Analyses at ASPN 2024 for SI-6603, an Investigational Treatment for Lumbar Disc Herniation
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring to present new data analyses at ASPN 2024 for SI-6603, an investigational treatment for lumbar disc herniation.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Seikagaku
Sign Up For FreeTo access detailed company insights
Founded in 1947, Seikagaku Corporation creates a range of medical devices and pharmaceuticals specifically related to glycoconjugates.... Read More
